Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective study [PDF]
Biomarker ResearchBone changes in patients undergoing pelvic radiotherapy remain unclear. This study initially utilized high-resolution peripheral quantitative computed tomography (HR-pQCT) to assess the dynamic changes in bone microarchitecture and volumetric bone ...
Weishi Cheng +9 more
doaj +2 more sources
GNE‐317 Reverses MSN‐Mediated Proneural‐to‐Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTOR [PDF]
Advanced ScienceGlioblastoma (GBM) resistance to chemoradiotherapy is a major factor contributing to poor treatment outcomes. This resistance markedly affects the effectiveness of surgery combined with chemoradiotherapy and leads to post‐surgical tumor recurrence ...
Yong‐Chang Yang +15 more
doaj +2 more sources
MicroRNA-330-5p as a putative modulator of neoadjuvant chemoradiotherapy sensitivity in oesophageal adenocarcinoma [PDF]
, 2015 Oesophageal adenocarcinoma (OAC) is the sixth most common cause of cancer deaths worldwide, and the 5-year survival rate for patients diagnosed with the disease is approximately 17%.
Bibby, Becky A S +3 more
core +10 more sources
Journal of the American Medical Association (JAMA), 2022 Importance Concurrent chemoradiotherapy has been the standard treatment for stage II nasopharyngeal carcinoma (NPC) based on data using 2-dimensional conventional radiotherapy.
L. Tang +24 more
semanticscholar +1 more source
Preoperative chemoradiotherapy for esophageal or junctional cancer.
New England Journal of Medicine, 2012 BACKGROUND The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in this patient population.
P. van Hagen +28 more
semanticscholar +1 more source
JAMA Surgery, 2021 Key Points Question Does treatment with neoadjuvant chemoradiotherapy plus surgery improve the long-term survival of patients with locally advanced esophageal squamous cell carcinoma (ESCC) compared with surgery alone?
Han Yang +25 more
semanticscholar +1 more source
Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): A feasibility study [PDF]
, 2006 Background: Concurrent chemoradiotherapy has improved survival in inoperable stage III non-small cell lung cancer (NSCLC). This phase I trial was performed in order to establish a dose recommendation for oral vinorelbine in combination with cisplatin and
Clamon G +17 more
core +1 more source
Technology in Cancer Research & Treatment, 2021 Purpose: Induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone are both standard treatment regimens for managing locally advanced nasopharyngeal carcinoma.
Guoqiang Xu MD +9 more
doaj +1 more source
Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
Frontiers in Oncology, 2021 PurposeTo identify whether chemoradiotherapy improves survival of stage I nasopharyngeal carcinoma (NPC).Materials and MethodsNPC patients were extracted from the Surveillance, Epidemiology, and End Results database between 2010 and 2015.
Jia-Lin Ma +3 more
doaj +1 more source
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
New England Journal of Medicine, 2018 BACKGROUND An earlier analysis in this phase 3 trial showed that durvalumab significantly prolonged progression‐free survival, as compared with placebo, among patients with stage III, unresectable non–small‐cell lung cancer (NSCLC) who did not have ...
S. Antonia +32 more
semanticscholar +1 more source